Login to Your Account

Other News To Note

Wednesday, July 24, 2013

• Mesoblast Ltd., of Melbourne, Australia, received about $4.3 million under the Australian government's Innovation Australia Research and Development Tax Incentive Program. The funds will be used to advance development of Mesoblast's mesenchymal precursor cell technology platform and product pipeline.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription